The Future of Pathology

Felix is joined by Professor Runjan Chetty, Chief Medical Officer of Deciphex, a company developing AI-based diagnostics for pathology samples. 

From neuropathology to skin pathology, from gynaecological pathology to gastrointestinal pathology, Professor Chetty and Deciphex aim to rapidly accelerate health care standards.

In this episode of the podcast, join me, Dr Felix Beacher, as I sit down with Professor Runjan Chetty, CEO of Deciphex, a company focused on utilizing AI to improve the delivery of pathology services. Professor Chetty discusses how digitalized slides can revolutionize a global approach to pathology by enhancing medical aid and practice in remote areas.

We delve into the benefits of utilizing AI in clinical trials, and how this technology can help us develop new treatments and therapies more efficiently. Professor Chetty shares some of the challenges that come with implementing AI in the healthcare industry such as regulatory safeguarding, and preclinical approval, and offers insights into how AI is accelerating safe med tech.

Guest Profile – Runjan Chetty

Professor Chetty is the Chief Medical Officer at Diagnexia. He is an experienced Anatomical Pathologist/Histopathologist with speciality interests in GI and pancreatic pathology who has held chairs of Pathology in South Africa and Glasgow.

Original music by Felix Beacher: https://youtu.be/JS93808r-W4